top of page
News, Events and Updates
Search
Jun 4, 2017
Anavex Life Sciences to Present at Jefferies 2017 Global Healthcare Conference
May 29, 2017
Jefferies 2017 Global Healthcare Conference June 6-9
May 21, 2017
Anavex Life Sciences Reports New Data for ANAVEX 2-73 in Neurodevelopmental Disorders
May 21, 2017
Anavex Life Sciences Reports New Data for ANAVEX 2-73 in Neurodevelopmental Disorders
May 16, 2017
Anavex President & CEO Christopher U. Missling, PhD, to present preclinical data on ANAVEX 2-73
May 9, 2017
Anavex Reports Fiscal Second Quarter 2017 Financial Results
Apr 30, 2017
Anavex Life Sciences Appoints Former FDA Officer as Senior Vice President of Regulatory Affairs
Apr 20, 2017
Anavex President & CEO Christopher U. Missling, PhD, to Participate in a Roundtable Discussion
Apr 2, 2017
New Mechanism of Action Data Related to ANAVEX Compounds Targeting Sigma-1 Receptor
Mar 31, 2017
The Dual Regulation of Oxidative Stress by SIGMA1 Receptors in Physiological/Pathological Conditions
Mar 29, 2017
Targeting M1 Muscarinic & Sigma1 Receptors in Alzheimer's Disease: Reversal of Pathological Hallmark
22
23
24
25
26
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
